PBP. Douglas Boatman
P. Douglas Boatman
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
P. Douglas Boatman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Andrew K. Taggart
Merck Research Laboratories, Rahway, NJ, USA
1 shared publicationBenjamin R. Johnson
Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
1 shared publicationCarleton R. Sage
Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
1 shared publicationEster Carballo-Jane
Merck Research Laboratories, Rahway, NJ, USA
1 shared publicationGraeme Semple
Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
1 shared publicationJae-Kyu Jung
Department of Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA
1 shared publication
Latest Publications
- 1 May 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2797-2800
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
- 1 May 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2797-2800
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
- 1 April 2003
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (8) , 1445-1449
High-throughput synthesis and optimization of thrombin inhibitors via urazole α-addition and Michael addition
- 1 April 2003
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (8) , 1445-1449
High-throughput synthesis and optimization of thrombin inhibitors via urazole α-addition and Michael addition